Hiv 1 Prevention clinical trials

Explore recruiting hiv 1 prevention clinical trials.

Recruiting hiv 1 prevention studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hiv 1 Prevention trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure Prophylaxis

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Hiv 1 Prevention trials by city

Hiv 1 Prevention in Toronto Hiv 1 Prevention in Vancouver Hiv 1 Prevention in Montreal Hiv 1 Prevention in Calgary Hiv 1 Prevention in Edmonton Hiv 1 Prevention in Ottawa Hiv 1 Prevention in Winnipeg Hiv 1 Prevention in Quebec City Hiv 1 Prevention in Hamilton Hiv 1 Prevention in Kitchener Hiv 1 Prevention in London Hiv 1 Prevention in Halifax Hiv 1 Prevention in New York Hiv 1 Prevention in Los Angeles Hiv 1 Prevention in Chicago Hiv 1 Prevention in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease